ncompensated members of the advisory board for Complete Genomics. H.L.R. is a compensated member of the advisory boards for GenomeQuest, Knome, and Omicia and uncompensated for BioBase and Clinical Future. B.R.K., H.L.R., and M.S.Wi. are involved with clinical laboratories offering genome sequencing

vested S0.Sitt in November 2011 in the form of convertible notes. Other investors included Leroy Flood and John Stupelnagel. In Oct 2013 — Jan 2014, Omicia raised a Series A round of $6.8m led by Artis Ventures and Laboratory Corporation of America. Invitae Inviate is a molecular diagnostic company st